购物车
您的购物车当前为空
α-Glucosidase-IN-55 (Compound 8g) 是一种口服活性和竞争性的α-葡萄糖苷酶 (
α-Glucosidase-IN-55 (Compound 8g) 是一种口服活性和竞争性的α-葡萄糖苷酶 (
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 10 mg | 待询 | 待询 | |
| 50 mg | 待询 | 待询 |
| 产品描述 | α-Glucosidase-IN-55 (Compound 8g) is an orally active, competitive inhibitor of α-glucosidase with an IC50 value of 12.1 µM and a Ki value of 9.66 µM. It is useful for research related to Type 2 Diabetes Mellitus (T2DM), as it can enhance glycemic control and metabolic health. |
| 体内活性 | α-Glucosidase-IN-55 以 2-8 mg/kg 剂量口服每日一次,持续 28 天,可显著降低糖尿病大鼠的空腹血糖 (FBG) 水平。 |
| 分子式 | C31H22ClN3S |
| 存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
以上为“体内实验配液计算器”的使用方法举例,并不是具体某个化合物的推荐配制方式,请根据您的实验动物和给药方式选择适当的溶解方案。
对于不同动物的给药剂量换算,您也可以参考 更多